Prevention of Venous Graft Disease After Coronary Artery Bypass Grafting: Is Ex Vivo Statin Exposure an Answer?

被引：2
作者：
Forcillo, Jessica [1 ]
Perrault, Louis P. [1 ]
机构：
[1] Univ Montreal, Dept Cardiac Surg, Montreal Heart Inst, Montreal, PQ, Canada
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2012年 / 28卷 / 06期
关键词：
EXPERIMENTAL VEIN GRAFTS; INTIMAL HYPERPLASIA; NEOINTIMAL HYPERPLASIA; INHIBITION; MODEL; STENOSIS; FAILURE; STRESS;
D O I：
10.1016/j.cjca.2012.04.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：623 / 625
页数：3
相关论文
共 21 条
  • [1] Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
  • [2] Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes
    Baguneid, M
    Murray, D
    Salacinski, HJ
    Fuller, B
    Hamilton, G
    Walker, M
    Seifalian, AM
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2004, 39 (02) : 151 - 157
  • [3] Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts
    Brauner, R
    Laks, H
    Drinkwater, DC
    Chaudhuri, G
    Shvarts, O
    Drake, T
    Bhuta, S
    Mishaly, D
    Fishbein, I
    Golomb, G
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (01) : 53 - 63
  • [4] Both ICAM-1-and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein
    Crook, MF
    Southgate, KM
    Newby, AC
    [J]. JOURNAL OF VASCULAR RESEARCH, 2002, 39 (03) : 221 - 229
  • [5] Lazaroid therapy (methylaminochroman:U83836E) reduces vein graft intimal hyperplasia
    Davies, MG
    Dalen, H
    Barber, L
    Svendsen, E
    Hagen, PO
    [J]. JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) : 128 - 136
  • [6] REDUCTION OF INTIMAL HYPERPLASIA AND ENHANCED REACTIVITY OF EXPERIMENTAL VEIN BYPASS GRAFTS WITH VERAPAMIL TREATMENT
    ELSANADIKI, MN
    CROSS, KS
    MURRAY, JJ
    SCHUMAN, RW
    MIKAT, E
    MCCANN, RL
    HAGEN, PO
    [J]. ANNALS OF SURGERY, 1990, 212 (01) : 87 - 96
  • [7] Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
    FitzGibbon, GM
    Kafka, HP
    Leach, AJ
    Keon, WJ
    Hooper, GD
    Burton, JR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (03) : 616 - 626
  • [8] OPTIMAL ANTITHROMBOTIC THERAPY FOLLOWING AORTOCORONARY BYPASS - A METAANALYSIS
    FREMES, SE
    LEVINTON, C
    NAYLOR, CD
    CHEN, E
    CHRISTAKIS, GT
    GOLDMAN, BS
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1993, 7 (04) : 169 - 180
  • [9] Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin
    Hu, YH
    Zou, YP
    Dietrich, H
    Wick, G
    Xu, QB
    [J]. CIRCULATION, 1999, 100 (08) : 861 - 868
  • [10] Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts
    Huynh, TTT
    Davies, MG
    Barber, L
    Svendsen, E
    Hagen, PO
    [J]. JOURNAL OF SURGICAL RESEARCH, 1998, 77 (02) : 104 - 111
123